Implementing the vaccine will be difficult

With a vaccine on the way, governments concerns now turn to who will get it first. Bidding for the new vaccine will likely put many poorer nations, and those with less influence, at a disadvantage. Trump has already contacted companies in Germany who are developing a vaccine. His aim was to buy exclusive access to the vaccine they are developing. Every nation will need doses of a vaccine in the near future, and this move was seen extremely unfavourably in Europe. German politicians have been outspoken about their disapproval, claiming that no country should be permitted to buy exclusive access to a vaccine^[1]. But even once a nation has the vaccine, there will be difficulty of distribution. Who gets the vaccine first? How do we administer it? The British manufacturer AstraZeneca has agreed to supply 100 million does to the UK. They are also looking to supply up to 2 billion doses globally^[2]. Governments all across the globe are preparing to implement what will likely be the largest ever vaccination campaign. This will require hiring large numbers of medical staff, strict timetables and additional facilities to cope with the large numbers of people coming to receive an injection. Talk of a vaccine has also seen backlash from anti-vaxxer communities. In 2019, their campaigns and reluctance to receive necessary injections lead to the largest measles outbreak in the US seen in a generation. Now, their discourse targets a COVID-19 vaccine. In May, a survey found that 23% of Americans do not want to receive this vaccine. This is troubling news. In order to stop the epidemic and return to some semblance of normality, we will all need to cooperate and this vaccine will be the best first step^[3].